The Proposed Drug Quality and Security Act (H.R. 3204) /
| Main Author: | Thaul, Susan (Author) |
|---|---|
| Format: | Government Document Database |
| Language: | English |
| Published: |
[Washington, D.C.] :
Congressional Research Service,
2020-
|
| Edition: | [Library of Congress public edition]. |
| Series: | CRS report ;
R43290. |
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/gpo141938 |
Similar Items
The Prescription Drug User Fee Act : history through the 2007 PDUFA IV reauthorization /
by: Thaul, Susan
Published: (2020)
by: Thaul, Susan
Published: (2020)
Securing Our Nation's Prescription Drug Supply Chain.
Published: (2013)
Published: (2013)
Examining the Drug Supply Chain.
Published: (2017)
Published: (2017)
Drug shortage crisis : lives are in the balance : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, November 30, 2011.
Published: (2012)
Published: (2012)
Drug Regulation Reform Act of 1978 : the administration proposal : section-by-section analysis, H.R. 11611 and S. 2755, 95th Congress, second session.
Published: (1978)
Published: (1978)
Perspectives of drug manufacturers : investigational new drug and new drug applications.
Published: (1990)
Published: (1990)
Pay to delay : are patent settlements that delay generic drug market entry anticompetitive? : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, June 3, 2009.
Published: (2010)
Published: (2010)
Why Are Some Generic Drugs Skyrocketing in Price?
Published: (2014)
Published: (2014)
Counterfeit Drugs : Fighting Illegal Supply Chains.
Published: (2014)
Published: (2014)
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019.
Published: (2021)
Published: (2021)
Perspectives of drug manufacturers : abbreviated new drug applications.
Published: (1990)
Published: (1990)
Regulation of over-the-counter (OTC) drugs /
by: Dabrowska, Agata
Published: (2018)
by: Dabrowska, Agata
Published: (2018)
State of Competition in the Pharmacy Benefits Manager and Pharmacy Marketplaces.
Published: (2015)
Published: (2015)
Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002.
Published: (2002)
Published: (2002)
FDA Risk Evaluation and Mitigation Strategies (REMS) : description and effect on generic drug development /
by: Dabrowska, Agata
Published: (2018)
by: Dabrowska, Agata
Published: (2018)
Prescription Drug Shortages : Examining a Public Health Concern and Potential Solutions.
Published: (2011)
Published: (2011)
The Competitive status of the U.S. pharmaceutical industry : the influences of technology in determining international industrial competitive advantage /
Published: (1983)
Published: (1983)
FDA Amendments Act of 2007 (P.L. 110-85) /
by: Thaul, Susan
Published: (2018)
by: Thaul, Susan
Published: (2018)
Examining Drug Shortages and Recent Efforts To Address Them.
Published: (2014)
Published: (2014)
Prescription drug discount coupons and patient assistance programs (PAPs) /
by: Kirchhoff, Suzanne M.
Published: (2018)
by: Kirchhoff, Suzanne M.
Published: (2018)
Prescription Drug User Fee Act (PDUFA) : 2012 reauthorization as PDUFA V /
by: Thaul, Susan
Published: (2019)
by: Thaul, Susan
Published: (2019)
Food and drugs act, index to notices of judgment 25001-26000.
Published: (1937)
Published: (1937)
Food and drugs act, index to notices of judgment 28001-29000.
Published: (1940)
Published: (1940)
Food and drugs act, index to notices of judgment 27001-28000.
Published: (1940)
Published: (1940)
Food and drugs act, index to notices of judgment 26001-27000.
Published: (1937)
Published: (1937)
FDA Checkup : Drug Development and Manufacturing Challenges.
Published: (2013)
Published: (2013)
Combating the Opioid Epidemic : Examining Concerns About Distribution and Diversion.
Published: (2018)
Published: (2018)
Food and drugs act, notices of judgment, index to nos. 10001-20000.
Published: (1936)
Published: (1936)
Examining the Impact of Voluntary Restricted Distribution Systems in the Pharmaceutical Supply Chain.
Published: (2017)
Published: (2017)
Pharmaceutical patenting practices : a legal overview /
by: Richards, Kevin T.
Published: (2020)
by: Richards, Kevin T.
Published: (2020)
States' collection of Medicaid rebates for physician-administered drugs.
Published: (2011)
Published: (2011)
60 minutes.
Published: (2005)
Published: (2005)
Regulatory exclusivity reform in the 115th Congress /
by: Thomas, John R., 1967-
Published: (2019)
by: Thomas, John R., 1967-
Published: (2019)
States' collection of rebates for drugs paid through Medicaid managed care organizations.
Published: (2012)
Published: (2012)
How FDA approves drugs and regulates their safety and effectiveness /
by: Dabrowska, Agata
Published: (2018)
by: Dabrowska, Agata
Published: (2018)
Prescription Drug User Fee Act (PDUFA) : 2017 reauthorization as PDUFA VI /
by: Dabrowska, Agata, et al.
Published: (2018)
by: Dabrowska, Agata, et al.
Published: (2018)
Prescription drug importation /
by: Sarata, Amanda K., et al.
Published: (2018)
by: Sarata, Amanda K., et al.
Published: (2018)
60 minutes.
Published: (2005)
Published: (2005)
FDA in the twenty-first century : the challenges of regulating drugs and new technologies /
Published: (2015)
Published: (2015)
Specialty drugs : background and policy concerns /
by: Kirchhoff, Suzanne M.
Published: (2018)
by: Kirchhoff, Suzanne M.
Published: (2018)